ALNYLAM ANNOUNCES POSITIVE INITIAL PHASE 1B DATA FOR BREZOSIRAN (ALN-HTT02) DEMONSTRATING DEEP AND DURABLE HUNTINGTIN LOWERING IN HUNTINGTON’S DISEASE

Reuters · 2d ago

Please log in to view news